Clos J P, Malet M, Emeriau J P
Sem Hop. 1979;55(33-34):1525-8.
A group of 47 elderly patients with various ailments and aged between 66 and 99 years were treated with tiapride: very good results were obtained in 7 cases of severe buccofacial dyskinesia, though the dosage had to go as high as 800 mg/day; results were excellent in 2 cases, good in 9, moderate in 5, and nil in 3 out of 19 patients with agitated states; overall results were good (1 failure) in 8 cases of alcoholism (4 acute and 4 chronic); 8 good results and 4 failures were noted in 12 patients with either cancer pain, or pain following zoster or due to arthrosis or migraine. The product was very well-tolerated by these elderly patients.
一组47名患有各种疾病、年龄在66岁至99岁之间的老年患者接受了硫必利治疗:7例严重口面部运动障碍患者取得了非常好的效果,尽管剂量不得不高达800毫克/天;19例激动状态患者中,2例效果极佳,9例良好,5例中等,3例无效果;8例酒精中毒患者(4例急性和4例慢性)总体效果良好(1例失败);12例患有癌症疼痛、带状疱疹后疼痛、关节病疼痛或偏头痛的患者中,8例效果良好,4例失败。这些老年患者对该产品耐受性良好。